---

CBC, Immature Platelets, Peripheral Smear & Sepsis: A Comprehensive Clinical Guide

---

1. Immature Platelet Fraction (IPF) in Dengue with Platelet Count 40,000 and Falling

What is IPF?

• IPF% - percentage of immature platelets out of total platelets
• Absolute IPF count (immature platelet count) - number per µL

Why is it sent in dengue with falling platelets?

Mechanisms of dengue thrombocytopenia:

1. Peripheral destruction - Dengue virus cross-reactive IgG antibodies (non-neutralizing, fucosylated IgG1) bind to FcγRIIIA on platelets AND cross-react with platelet antigens, causing immune-mediated destruction (Dermatology 5e - Viral Hemorrhagic Fevers)
2. Direct BM suppression - DENV infects megakaryocytes, impairing platelet production
3. Platelet consumption - capillary leakage, endothelial activation, and coagulopathy consume platelets
4. Sequestration - in the spleen and liver

IPF tells you WHICH mechanism is dominant:

• High IPF → destruction/consumption dominant → marrow is compensating → patient will recover if supported
• Low IPF → BM suppression dominant → no production → higher risk, may need transfusion sooner

Other CBC clues in dengue:

---

2. Significance of CBC in Shock and Sepsis

WBC Changes:

Platelet Changes:

Hemoglobin/Hematocrit:

• Low Hb: Anemia of inflammation, hemodilution, bleeding
• Rising Hct: Hemoconcentration - dehydration/plasma loss (as in dengue shock)
• Falling Hct: Active hemorrhage - critical emergency

RBC Indices / Smear:

• Fragmented RBCs (schistocytes) on smear: DIC or TTP/HUS complicating sepsis - urgent diagnosis

---

3. Peripheral Smear Changes in Sepsis

Neutrophil Changes (Most Important)

Clinical tip: The triad of toxic granulation + Döhle bodies + left shift on a smear is highly predictive of bacterial sepsis even before culture results.

Platelet Changes on Smear:

• Thrombocytopenia with schistocytes = sepsis-induced DIC / TMA
• Giant platelets = reactive thrombopoiesis (bone marrow responding)
• Platelet clumping = rule out pseudothrombocytopenia (EDTA artifact)

RBC Changes:

• Schistocytes (helmet cells, triangle cells): DIC, sepsis-associated TMA
• Spherocytes: Can appear in DIC
• Polychromasia: Reticulocytosis after hemorrhage or hemolysis

---

4. Early Detection of Sepsis: Clinical Examination + Basic CBC

Clinical (General Examination) Red Flags for Early Sepsis:

• Fever >38.3°C or Hypothermia <36°C (hypothermia = worse prognosis)
• "Temperature gap" - feel cool extremities despite core fever = poor peripheral perfusion

• Tachycardia >90/min (often the first sign)
• Tachypnea >20/min (respiratory compensation for metabolic acidosis)
• Hypotension SBP <90 mmHg or MAP <65 (= septic shock when vasopressors needed)
• Narrow pulse pressure

• Mottled skin (especially knees) - microcirculatory failure
• Prolonged capillary refill time >2 seconds
• Cold, clammy extremities with warm core = distributive shock
• Icterus = hepatic involvement / hemolysis

• Altered mental status, confusion, agitation (sepsis-associated encephalopathy)
• Somnolence = advanced sepsis

• Oliguria <0.5 mL/kg/hr = hypoperfusion of kidneys

---

Early CBC Flags for Sepsis (Even Before Cultures):

The NLR (Neutrophil-to-Lymphocyte Ratio) - Practical Tool:

• Normal: ~1-3
• NLR 5-10: Significant systemic inflammation / early sepsis
• NLR >10: Severe sepsis, critical illness, poor prognosis
• NLR >15-20: Associated with ICU admission and mortality

---

Quick Summary Algorithm for Bedside Sepsis Screening:

CLINICAL: Fever/hypothermia + tachycardia + tachypnea + altered mental status?
        ↓
CBC: WBC <4 or >12k? Bands on differential? Eosinopenia? Thrombocytopenia?
        ↓
CALCULATE: NLR >5? PLR elevated? Falling platelet trend?
        ↓
SMEAR: Toxic granulation? Döhle bodies? Left shift? Schistocytes?
        ↓
LACTATE (if available): >2 mmol/L = tissue hypoperfusion even before BP falls

---

Key Points Summary

1. IPF in dengue distinguishes destructive (peripheral, IPF high - good, BM working) from suppressive (IPF low - dangerous, BM failing) thrombocytopenia. Guides timing of platelet transfusion.
2. CBC in shock/sepsis reveals leukocytosis/leukopenia, thrombocytopenia, falling Hb, rising or falling Hct - each pointing to mechanism and severity.
3. NLR and eosinopenia are the two most underused but powerful early sepsis flags from a standard CBC.
4. Peripheral smear toxic granulation + Döhle bodies + left shift = bacterial sepsis triad. Schistocytes = DIC/TMA complicating sepsis.
5. Earliest bedside signs: tachycardia, mottled skin, prolonged cap refill, eosinopenia on CBC - often precede hypotension by hours.

---

---

Steroids in Dengue and Other Infectious Diseases: Indications, Evidence, and Mechanisms

---

PART 1: Inj. Hydrocortisone in Dengue Fever

Short Answer: Generally NOT recommended. No proven benefit, potential harm.

• Plasma leakage from vascular endothelium
• Immune-mediated platelet destruction
• Cytokine storm (though shorter and more self-limiting than bacterial sepsis)

"Treatment with corticosteroids or chloroquine was shown to be not beneficial." - Brenner & Rector's The Kidney

Why Steroids Are NOT Given in Routine Dengue:

When Might a Clinician Still Consider Steroids in Dengue? (Very Limited Scenarios)

---

PART 2: Indications for IV Steroids in Infectious Diseases

Evidence-Based Indications (Grade A or Strong Evidence):

---

1. Bacterial Meningitis - Dexamethasone

• Cochrane review: "dexamethasone leads to a major reduction in hearing loss and death in both children and adults with bacterial meningitis, without major adverse effects" - Roberts & Hedges Clinical Procedures in EM
• Greatest benefit in S. pneumoniae meningitis in adults (mortality reduction)
• Benefit in H. influenzae meningitis in children (reduced hearing loss)
• KEY: Must be given BEFORE antibiotics - giving it after antibiotic-triggered lysis is too late

---

2. Septic Shock - Hydrocortisone (Low Dose)

• Restores vascular sensitivity to vasopressors
• Reduces time on vasopressors
• Modest 28-day mortality reduction (RR 0.90, 95% CI 0.82-0.98 per 2019 meta-analysis - PMID: 34484209)

---

3. Pneumocystis jirovecii Pneumonia (PCP) - Prednisone/Methylprednisolone

• Prednisone 40 mg BD x 5 days → 40 mg OD x 5 days → 20 mg OD x 11 days (total 21 days)
• If IV needed: Methylprednisolone at 75% of prednisone dose

---

4. Tuberculous Meningitis (TBM) - Dexamethasone

---

5. Enteric Fever (Typhoid) with Severe Neurological Complications

---

6. Herpes Simplex Encephalitis - Adjunctive Dexamethasone (Evolving Evidence)

---

7. SARS-CoV-2 / Severe COVID-19 - Dexamethasone

---

8. Immune Reconstitution Inflammatory Syndrome (IRIS) in HIV

---

Summary Table: IV Steroids in Infectious Diseases

---

The Core Clinical Principle

Use steroids in infections only when: the bug is controlled (antibiotics given), AND the immune response is the killer (cytokine storm, cerebral inflammation, ARDS), AND evidence supports it.

Never use steroids when: the infection is self-limiting, the bug is not controlled, there is ongoing coagulopathy/bleeding risk (like dengue), or the evidence shows no benefit.

---

---

IV Hydrocortisone in Malaria: The Answer is Almost Always NEVER

---

The Bottom Line

---

The Historical Background

• Cerebral malaria causes brain edema
• Steroids reduce cerebral edema (as in bacterial meningitis)
• Therefore steroids should help

---

The Definitive Evidence Against Steroids in Malaria

Warrell et al. (1982) - NEJM - The Landmark Trial

• Patients receiving dexamethasone had a longer duration of coma than controls
• Worse clinical outcome than those on antimalarials alone
• More gastrointestinal bleeding and seizures in the steroid group
• No mortality benefit whatsoever

---

Cochrane Review (Prasad & Garner 2000) - [PMID 10796562]

• Pooled 2 RCTs, 143 patients
• No evidence of benefit from steroids on mortality
• Significant increase in GI bleeding and seizures in the steroid group
• Prolonged coma recovery time in steroid group
• Conclusion: No evidence of benefit; evidence of harm

---

Why Steroids Are Harmful in Malaria (Mechanisms)

1. Prolonging coma through unknown mechanisms
2. Increasing seizure threshold disruption
3. Promoting GI hemorrhage (especially with thrombocytopenia)
4. Immunosuppression - potentially slowing parasite clearance
5. Worsening hypoglycemia (a major killer in cerebral malaria, especially children)

---

WHO Current Position (2024)

"The WHO does not recommend corticosteroids, osmotic agents (including mannitol), or acetazolamide for cerebral malaria management."

---

What IS the Correct Management of Severe/Cerebral Malaria?

---

The Only Scenario Where Steroids Have a Role in a Malaria Patient

---

Summary in One Line

Never prescribe IV hydrocortisone or any steroid for malaria itself. It prolongs coma, increases complications, and does not reduce mortality. WHO, Cochrane, and the landmark Warrell 1982 NEJM trial all agree. Treat malaria with IV artesunate.

---